QVIDTVM Management LLC
CIK 1912226 · View on SEC EDGAR ↗
- Portfolio value
- $76.6M
- Positions
- 14
- As of
- June 30, 2026
Portfolio value QoQ: -5.9% 13F does not disclose cash
- Top 10 holdings weight
- 99.22%
- Top 25 holdings weight
- 100.00%
- Positions above 1%
- 9
- Effective number of positions
- 6.4
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q2 2026: 9.4% Est. buys $7,424,637 · sells $29,005,968
Median holding: 3.0 quarters Tracked Q4 2024–Q2 2026 · 77.8% still held
- New positions
- 1
- Increased
- 3
- Decreased
- 10
- Closed
- 1
On this page
- Performance vs S&P How this manager's 13F portfolio performed against the S&P 500.
- Sector breakdown How the portfolio splits across market sectors.
- Portfolio Every stock this institution reports holding, from its latest 13F.
- Biggest new bets Brand-new positions opened in the latest quarter.
- Top moves The biggest position increases and decreases this quarter.
- Exited positions Positions the manager fully sold out of last quarter.
Performance vs S&P 500
Annualized: +3.0% · S&P 500: +18.0%
Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.
Priceable coverage: 99.7% · Options excluded: 0.0%
Sector breakdown
Full portfolio 14 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| BIO Bio-Rad Laboratories, Inc. Class A Common Stock | $19,449,607 | 25.39% | 66,243 | $-3,890,688 | Down ×1 | ||
| NBIS Nebius Group N.V. - Class A Ordinary Shares | $13,437,604 | 17.54% | 48,657 | $7,141,655 | Down ×1 | ||
| AMRZ Amrize Ltd Ordinary Shares | $13,185,940 | 17.21% | 247,391 | $1,004,055 | Up ×2 | ||
| ORCL Oracle Corporation Common Stock | $8,348,954 | 10.90% | 56,970 | $2,626,081 | Up ×1 | ||
| SOLV Solventum Corporation Common Stock | $6,868,896 | 8.97% | 89,033 | $-10,475,764 | Down ×6 | ||
| ZGN Ermenegildo Zegna N.V. Ordinary Shares | $5,934,568 | 7.75% | 455,804 | $454,763 | Down ×1 | ||
| ARE Alexandria Real Estate Equities, Inc. Common Stock | $4,358,540 | 5.69% | 82,470 | $2,501,740 | Up ×1 | ||
| BRCC BRC Inc. Class A Common Stock | $3,277,983 | 4.28% | 2,953,138 | $638,374 | Down ×1 | ||
| Unknown issuer (CUSIP: G22845104) | $936,696 | 1.22% | 57,466 | Up ×1 | |||
| WAB Westinghouse Air Brake Technologies Corporation Common Stock | $202,200 | 0.26% | 750 | $-490,051 | Down ×6 | ||
| XRAY DENTSPLY SIRONA Inc. - Common Stock | $200,837 | 0.26% | 18,929 | $-4,269,907 | Down ×3 | ||
| PM Philip Morris International Inc Common Stock | $185,614 | 0.24% | 1,026 | $7,212 | Down ×1 | ||
| LAB Standard BioTools Inc. - Common Stock | $182,639 | 0.24% | 222,000 | $-28,191 | Down ×1 | ||
| HRB H&R Block, Inc. Common Stock | $32,140 | 0.04% | 844 | $-705,974 | Down ×1 | ||
| No matches | |||||||
Biggest new bets
New positions opened this quarter, largest first.
| Security | Value | Shares | % of portfolio |
|---|---|---|---|
| Unknown issuer (CUSIP: G22845104) | $936,696 | 57,466 | 1.22% |
Top movers (QoQ)
| Security | Action | Shares Δ | Value Δ |
|---|---|---|---|
| SOLV | Trimmed | -177K | -$10.5M |
| NBIS | Trimmed | -12K | +$7.1M |
| BIO | Trimmed | -17K | -$3.9M |
| ORCL | Bought more | +18K | +$2.6M |
| ARE | Bought more | +42K | +$2.5M |
| AMRZ | Bought more | +30K | +$1.0M |
| BRCC | Trimmed | -448K | +$638K |
| WAB | Trimmed | -2K | -$490K |
| ZGN | Trimmed | -70K | +$455K |
| LAB | Trimmed | -7K | -$28K |
2 positions hidden (data completeness check)
Exited positions
Includes corporate events (mergers, delistings) — not all exits are sells
Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.